Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

J.P. Morgan analyst Seiji Wakao maintained a Hold rating on PHC Holdings Corp. (2GY – Research Report) yesterday and set a price target of ...

DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

Federal agencies have removed web pages dedicated to DEI programs related to cancer research and other clinical research.

The Conference Forum has announced the 9th annual Patients as Partners® Europe event, scheduled for May 20-21, 2025, at the Royal National Hotel ...